Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

90 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
A phase IIb dose-ranging study of the oral JAK inhibitor tofacitinib (CP-690,550) versus placebo in combination with background methotrexate in patients with active rheumatoid arthritis and an inadequate response to methotrexate alone.
Kremer JM, Cohen S, Wilkinson BE, Connell CA, French JL, Gomez-Reino J, Gruben D, Kanik KS, Krishnaswami S, Pascual-Ramos V, Wallenstein G, Zwillich SH. Kremer JM, et al. Arthritis Rheum. 2012 Apr;64(4):970-81. doi: 10.1002/art.33419. Epub 2011 Oct 17. Arthritis Rheum. 2012. PMID: 22006202 Free article. Clinical Trial.
Association of significant risk perception with the use of complementary and alternative medicine: A cross-sectional study in Hispanic patients with rheumatoid arthritis.
Contreras-Yáñez I, Cabrera-Vanegas Á, Robledo-Torres A, Cáceres-Giles C, Valverde-Hernández S, Padilla-Ortiz D, Guaracha-Basáñez GA, Pascual-Ramos V. Contreras-Yáñez I, et al. PLoS One. 2020 Aug 13;15(8):e0237504. doi: 10.1371/journal.pone.0237504. eCollection 2020. PLoS One. 2020. PMID: 32790722 Free PMC article.
Evaluation of medical ethics competencies in rheumatology: local experience during national accreditation process.
Pascual-Ramos V, Contreras-Yáñez I, Arce Salinas CA, Saavedra Salinas MA, Del Mercado MVDM, López Zepeda J, Muñoz López S, Vázquez-Mellado J, Amezcua Guerra LM, Fragoso Loyo HE, Villarreal Alarcón MA, Pérez Cristobal M, Rubio Pérez EN, Torres Jiménez AR, Maldonado MDR, Álvarez-Hernández E; Mexican Accreditation Council for Rheumatology. Pascual-Ramos V, et al. J Med Ethics. 2019 Dec;45(12):839-842. doi: 10.1136/medethics-2019-105717. Epub 2019 Oct 11. J Med Ethics. 2019. PMID: 31604831
Smoking cessation is associated with lower disease activity and predicts cardiovascular risk reduction in rheumatoid arthritis patients.
Roelsgaard IK, Ikdahl E, Rollefstad S, Wibetoe G, Esbensen BA, Kitas GD, van Riel P, Gabriel S, Kvien TK, Douglas K, Wållberg-Jonsson S, Rantapää Dahlqvist S, Karpouzas G, Dessein PH, Tsang L, El-Gabalawy H, Hitchon CA, Pascual-Ramos V, Contreras-Yáñez I, Sfikakis PP, González-Gay MA, Crowson CS, Semb AG. Roelsgaard IK, et al. Rheumatology (Oxford). 2020 Aug 1;59(8):1997-2004. doi: 10.1093/rheumatology/kez557. Rheumatology (Oxford). 2020. PMID: 31782789 Free PMC article.
Musculoskeletal ultrasound to complement clinical evaluation and drive treatment of rheumatoid arthritis patients in remission does not prevent worsening of patient-reported outcomes: the ULTRAPRO randomised controlled study.
Sifuentes-Cantú C, Butrón-Hernández D, Contreras-Yáñez I, Pascual-Ramos V. Sifuentes-Cantú C, et al. Clin Exp Rheumatol. 2020 Nov-Dec;38(6):1182-1190. Epub 2020 Mar 28. Clin Exp Rheumatol. 2020. PMID: 32242808 Free article. Clinical Trial.
90 results